Back to Search Start Over

Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in USH2A Retinopathy.

Authors :
Charng J
Lamey TM
Thompson JA
McLaren TL
Attia MS
McAllister IL
Constable IJ
Mackey DA
De Roach JN
Chen FK
Source :
Translational vision science & technology [Transl Vis Sci Technol] 2020 Sep 09; Vol. 9 (10), pp. 9. Date of Electronic Publication: 2020 Sep 09 (Print Publication: 2020).
Publication Year :
2020

Abstract

Purpose: Microperimetry is commonly used to assess retinal function. We perform cross-sectional and longitudinal analysis on microperimetry parameters in USH2A retinopathy and explore end points suitable for future clinical trials.<br />Methods: Microperimetry was performed using two grids, Grid 1 (18° diameter) and Grid 2 (6° diameter). In Grid 1, four parameters (number of nonscotomatous loci, mean sensitivity [MS], responding point sensitivity [RPS], and edge of scotoma sensitivity [ESS]) were analyzed. In Grid 2, number of nonscotomatous loci and MS were examined. Interocular symmetry was also examined. Longitudinal analysis was conducted in a subset of eyes.<br />Results: Microperimetry could be performed in 16 of 21 patients. In Grid 1 ( n = 15; average age, 35.6 years), average number of nonscotomatous loci, MS, RPS, and ESS were 46.6 loci, 10.0 dB, 14.7 and 9.6 dB, respectively. In Grid 2 ( n = 13; average age, 37.4 years), 12 eyes had measurable sensitivity across the entire grid. Average MS was 23.8 dB. Interocular analysis revealed large 95% confidence intervals for all parameters. Longitudinally, Grid 1 ( n = 12, average follow-up 2.6 years) ESS showed the fastest rate of decline (-1.84 dB/y) compared with MS (-0.34 dB/y) and RPS (-0.90 dB/y).<br />Conclusions: Our data suggest that ESS may be more useful than MS and RPS in test grids that cover a large extent of the macula. We caution the use of contralateral eye as an internal control.<br />Translational Relevance: ESS may decrease the duration or sample size of treatment trials in USH2A retinopathy.<br />Competing Interests: Disclosure: J. Charng, None; T.M. Lamey, None; J.A. Thompson, None; T.L. Mclaren, None; M.S. Attia, None; I.L. McAllister, None; I.J. Constable, None; D.A. Mackey, None; J.N. De Roach, None; F.K. Chen, None<br /> (Copyright 2020 The Authors.)

Details

Language :
English
ISSN :
2164-2591
Volume :
9
Issue :
10
Database :
MEDLINE
Journal :
Translational vision science & technology
Publication Type :
Academic Journal
Accession number :
32974081
Full Text :
https://doi.org/10.1167/tvst.9.10.9